99.89

2.15% 2.1209

Irhythm Technologies Inc (IRTC)

Overview News Price History Option Chain Financials Discussions Forecast

Irhythm Technologies Inc stock is traded at $99.89, with a volume of 27,900. It is up +2.15% in the last 24 hours and down -10.91% over the past month. iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Previous Close:

$97.77

Open:

$99.28

24h Volume:

27,900

Relative Volume:

0.07

Market Cap:

$3.13B

Revenue:

$560.03M

Net Income/Loss:

$-150.66M

P/E Ratio:

-20.55

EPS:

-4.86

Net Cash Flow:

$-87.43M

1W Performance:

-1.84%

1M Performance:

-10.91%

6M Performance:

+30.37%

1Y Performance:

-4.84%

1-Day Range:

$98.83

$101.07

1-Week Range:

$95.50

$106.00

52-Week Range:

$55.92

$128.52

Irhythm Technologies Inc Stock (IRTC) Company Profile

Name

Irhythm Technologies Inc

Sector

Healthcare (1171)

Industry

Medical Devices (159)

Phone

415-632-5700

Address

699 8TH STREET, San Francisco, CA

Employee

2,000

Twitter

@iRhythmTech

Next Earnings Date

2024-10-30

Latest SEC Filings

IRTC's Discussions on Twitter

Compare IRTC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRTC Irhythm Technologies Inc	99.89	3.13B	560.03M	-150.66M	-87.43M	-4.86
ABT Abbott Laboratories	126.15	221.85B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	96.12	142.24B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	368.77	140.07B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	92.94	118.98B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	68.33	40.31B	5.72B	4.17B	259.90M	6.97

Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-03-24	Resumed	Wells Fargo	Equal Weight
Oct-04-24	Initiated	Goldman	Neutral
Jun-20-24	Upgrade	Wolfe Research	Peer Perform → Outperform
Dec-11-23	Upgrade	Citigroup	Neutral → Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Feb-07-23	Initiated	Wells Fargo	Overweight
Nov-07-22	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-09-22	Downgrade	Citigroup	Buy → Neutral
Apr-06-22	Initiated	Wolfe Research	Underperform
Feb-24-22	Upgrade	Needham	Hold → Buy
Jan-18-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-12-22	Upgrade	BTIG Research	Neutral → Buy
Jan-11-22	Upgrade	Oppenheimer	Perform → Outperform
Dec-21-21	Resumed	Canaccord Genuity	Buy
Dec-17-21	Upgrade	JP Morgan	Neutral → Overweight
Dec-15-21	Upgrade	Citigroup	Neutral → Buy
Jun-02-21	Downgrade	Citigroup	Buy → Neutral
Apr-13-21	Downgrade	BTIG Research	Buy → Neutral
Apr-12-21	Downgrade	JP Morgan	Overweight → Neutral
Feb-26-21	Downgrade	Colliers Securities	Buy → Neutral
Jan-29-21	Reiterated	Needham	Hold
Nov-17-20	Downgrade	Oppenheimer	Outperform → Perform
Sep-11-20	Initiated	Needham	Hold
Sep-02-20	Initiated	Robert W. Baird	Neutral
Aug-07-20	Upgrade	Colliers Securities	Neutral → Buy
Aug-05-20	Upgrade	Oppenheimer	Perform → Outperform
Mar-05-20	Initiated	Citigroup	Buy
Feb-06-20	Initiated	BTIG Research	Buy
Jan-10-20	Initiated	William Blair	Outperform
Jan-08-20	Initiated	SunTrust	Buy
Oct-22-19	Initiated	Oppenheimer	Perform
Feb-20-19	Downgrade	Chardan Capital Markets	Buy → Neutral
Sep-13-18	Reiterated	Canaccord Genuity	Buy
Sep-06-18	Initiated	Chardan Capital Markets	Buy
Aug-02-18	Upgrade	Dougherty & Company	Sell → Neutral
Jul-16-18	Downgrade	Dougherty & Company	Neutral → Sell
Dec-01-17	Initiated	Dougherty & Company	Neutral

View All

Irhythm Technologies Inc Stock (IRTC) Latest News

Mar 13, 2025